Home Cart Sign in  
Chemical Structure| 178946-89-9 Chemical Structure| 178946-89-9

Structure of C-DIM12
CAS No.: 178946-89-9

Chemical Structure| 178946-89-9

C-DIM12

CAS No.: 178946-89-9

C-DIM12 is Nurr1 activator that stimulates Nurr1 mediated apoptosis axis in bladder cancer cells and tumors and inhibits NF-κB–dependent gene expression in glial cells.

Synonyms: 4-Chlorophenyl-3,3'-diindolylmethane; DIM-C-pPhCl

4.5 *For Research Use Only !

Cat. No.: A179040 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
50mg łÇÿò¶ÊÊ Inquiry Inquiry
100mg łËòò¶ÊÊ Inquiry Inquiry
250mg łÍÿ˶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 50mg

    łÇÿò¶ÊÊ

  • 100mg

    łËòò¶ÊÊ

  • 250mg

    łÍÿ˶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of C-DIM12

CAS No. :178946-89-9
Formula : C23H17ClN2
M.W : 356.85
SMILES Code : ClC1=CC=C(C(C2=CNC3=C2C=CC=C3)C4=CNC5=C4C=CC=C5)C=C1
Synonyms :
4-Chlorophenyl-3,3'-diindolylmethane; DIM-C-pPhCl
MDL No. :MFCD05625919
InChI Key :LTLRXTDMXOFBDW-UHFFFAOYSA-N
Pubchem ID :5302583

Safety of C-DIM12

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BV-2 cells 10 μM 24 hours Increased CB2 receptor mRNA level PMC9433450
SH-SY5Y cells 10 μM 72 hours C-DIM12 significantly increased SYNGR3 protein expression PMC8998927
Primary murine synovial fibroblasts 10 μM 1 hour pretreatment followed by 12 hours C-DIM12 suppressed TNF α-induced VCAM-1 and ICAM-1 expression and reduced PGE2 and COX-2 production. PMC6138555
PC12 cells 0–20 μM 18 hours C-DIM12 activated NR4A2-dependent transactivation in PC12 cells, indicating its action through Nurr1. PMC5941193
Primary microglia 10 μM 24 hours Enhanced nuclear translocation of Nurr1 and suppressed LPS-induced IL-6 and NOS2 expression. PMC4429718
NF-κB-GFP HEK293 reporter cells 100 μM 24 hours Reduced TNFα-induced NF-κB activation, comparable to the positive control Bay-11. PMC4429718
BV-2 microglia 10 μM 24 hours Inhibited LPS-induced expression of NF-κB-regulated genes (e.g., NOS2, IL-6, CCL2), with effects attenuated by Nurr1-RNA interference. PMC4429718

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice Intracerebral hemorrhage model Oral 50 or 100 mg/kg Once daily for three days C-DIM12 improved the recovery of neurological function and prevented neuron loss in the hematoma, while suppressed activation of microglia/macrophages and expression of inflammatory mediators interleukin-6 and CC chemokine ligand 2. In addition, C-DIM12 as well as amodiaquine preserved axonal structures in the internal capsule and axonal transport function. PMC9246855
C57BL/6J mice Young mice Oral gavage 10, 35 or 100 mg/kg Young mice: single dose; aged mice: 5 consecutive days C-DIM12 enhances long-term spatial memory in young mice and rescues memory deficits in aged mice. PMC6917472
C57BL/6J mice Aged mice Oral gavage 35 mg/kg Young mice: single dose; aged mice: 5 consecutive days C-DIM12 enhances long-term spatial memory in young mice and rescues memory deficits in aged mice. PMC6917472
C57BL/6 mice MPTP-induced Parkinson's disease model Oral gavage 25 mg/kg Once daily for 14 days C-DIM12 protected dopaminergic neurons in the substantia nigra pars compacta, reduced microglial and astrocytic activation, and improved motor function. PMC5941193
Transgenic NF-κB/EGFP reporter mice MPTP and probenecid-induced Parkinson's disease model Oral gavage 50 mg/kg Once daily for 7 days C-DIM12 had the greatest neuroprotective activity in MPTPp-treated mice, and was also the most potent compound in suppressing activation of microglia and astrocytes, expression of cytokines and chemokines in quantitative polymerase chain reaction (qPCR) array studies, and in reducing expression of NF-κB/EGFP in the SN. C-DIM12 prevented nuclear export of Nurr1 in dopaminergic neurons and enhanced expression of the Nurr1-regulated proteins tyrosine hydroxylase and the dopamine transporter. PMC4306720
C57BL/6 mice Parkinson’s disease model Oral 50 mg/kg Once daily for 7 days Oral administration of C-DIM12 after one week of exposure to MPTP and probenecid prevented further loss of dopaminergic neurons in the substantia nigra pars compacta and striatal dopamine terminals, indicating that these compounds could be effective therapeutic agents to prevent neurodegeneration. PMC6067390

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.80mL

0.56mL

0.28mL

14.01mL

2.80mL

1.40mL

28.02mL

5.60mL

2.80mL

References

 

Historical Records

Categories